ClinConnect ClinConnect Logo
Search / Trial NCT04735835

Personalized Responses to Dietary Composition Trial 3

Launched by ZOE GLOBAL LIMITED · Jan 29, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gut Microbiome Personalised Nutrition Machine Learning Postprandial Metabolism Metabolic Health

ClinConnect Summary

The PREDICT 3 study is looking to understand how different people react to various foods in order to give personalized dietary advice. It builds on previous research involving over 2,000 individuals and aims to create better predictions about how our bodies respond to meals, especially after eating. Participants will have the opportunity to take part in a controlled meal study and also track their real-life eating habits over time. This research is unique because it uses data collected from a commercial program, allowing for a larger group of participants who are already gathering useful health information through digital tools.

To join the study, participants need to be at least 18 years old, living in the continental U.S. (except New York) or the UK, and enrolled in the ZOE testing program. They should also have a body mass index (BMI) of 16.5 or higher and be under care for chronic health conditions, such as diabetes, while ensuring it's safe for them to participate. Those who join can expect to provide dietary records and participate in meal tests, helping researchers learn more about how diet affects health. It's important to note that certain individuals, like pregnant women or those who recently experienced serious health events, will not be eligible for this study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Enrolled in the commercial ZOE testing program
  • Any sex
  • Minimum 18 years of age (minimum 19 years of age in Alabama and Nebraska due to state laws)
  • Body mass index (BMI) of greater than or equal to 16.5 kg/m2.
  • Living in the continental US states, other than in New York (excluded from the ZOE testing product also as they are unable to access the dried blood spot service provided by Quest), or living in the UK
  • Able and willing to comply with the study protocol and provide informed consent.
  • Under care for chronic medical conditions (including eating disorders, type 1 diabetes, type 2 diabetes), and confirm they have checked with their primary care physician that this study is safe for them (US cohort only)
  • Exclusion Criteria:
  • Cannot safely eat the pre-made test meals which contain standard US ingredients, e.g. due to allergy or recent gastrointestinal surgery, or are unwilling to consume these foods.
  • Are pregnant.
  • Have had a heart attack (myocardial infarction), stroke/transient ischemic attack (TIA), or major surgery in the last two months.
  • Are unable to read and write in English, as the ZOE app is only available in English.

About Zoe Global Limited

Zoe Global Limited is a pioneering clinical trial sponsor dedicated to advancing personalized medicine through innovative research and development. With a focus on leveraging cutting-edge technologies and data analytics, the company aims to enhance therapeutic outcomes in various disease areas. Committed to rigorous scientific standards and ethical practices, Zoe Global Limited collaborates with healthcare professionals, academic institutions, and regulatory bodies to facilitate the efficient design and execution of clinical trials. Their mission is to transform healthcare by delivering impactful solutions that improve patient lives and drive the future of medical science.

Locations

London, , United Kingdom

Needham, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Tim Spector, PhD

Principal Investigator

Zoe Global Limited

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials